Drug or treatment

Panitumumab clinical trials

• 18Clinical trials
• 38Countries

Newest trials

All recruiting trials (18)

• Targeted dual-imaging helper for head and neck cancer surgery

  This study tests whether using two imaging agents during surgery can help doctors see tumors and cancerous lymph nodes in adults with head and neck squamous cell carcinoma.

  Recruiting Phase 1 Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT07741643

• Panitumumab-IRDye800 for guiding brain tumor surgery

  A tiny dose of panitumumab-IRDye800 is tested to see if it helps visualize brain tumors during surgery in adults.

  Recruiting Early Phase 1 Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT07493447

• Continuing sotorasib with or without panitumumab for adults with KRAS p.G12C advanced solid tumors

  This trial tries continuing sotorasib, with or without panitumumab, in adults with KRAS p.G12C advanced solid tumors who are already benefiting from an Amgen trial to see if ongoing treatment remains safe and tolerable.

  Recruiting at 9 sites Phase 2 Amgen · Fort Myers, Florida and 10 other locations · NCT07172919

• Adding panitumumab to chemotherapy for unresectable or metastatic KRAS wild-type pancreatic cancer

  This trial will test whether giving the antibody panitumumab along with standard chemotherapy helps people with unresectable, locally advanced, or metastatic KRAS wild-type pancreatic cancer live longer.

  Recruiting at 272 sites Phase 3 SWOG Cancer Research Network · Anchorage, Alaska and 273 other locations · NCT06998940

• Combining Dabrafenib with FOLFOX and Cetuximab/Panitumumab for Metastatic Colorectal Cancer

  This study is testing if a new combination of chemotherapy and targeted treatments can help people with metastatic colorectal cancer that has a specific mutation feel better and live longer.

  Recruiting Phase 2 Blokhin's Russian Cancer Research Center · Moscow · NCT06978400

• Evaluating a new treatment for metastatic colorectal cancer

  This study is testing a new drug combined with standard chemotherapy to see if it helps adults with metastatic colorectal cancer feel better and improve their condition.

  Recruiting at 82 sites Phase 2 AbbVie · Duarte, California and 81 other locations · NCT06820463

• Using a fluorescently labeled drug to improve surgery for head and neck cancer

  This study is testing a special version of a cancer drug to see if it can help doctors see tumors better during surgery for patients with head and neck cancer.

  Recruiting Phase 1 Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT06819228

• Comparing intermittent and continuous treatment for metastatic colorectal cancer

  This study is testing whether taking a cancer treatment in breaks instead of continuously can work just as well for people with a specific type of metastatic colorectal cancer.

  Recruiting Phase 3 National Cancer Institute, Naples · Naples · NCT06509126

• Comparing new treatments for metastatic colorectal cancer with a specific mutation

  This study is testing if a new combination of treatments can help people with a specific type of metastatic colorectal cancer feel better compared to standard treatments.

  Recruiting at 231 sites Phase 3 Amgen · Chandler, Arizona and 290 other locations · NCT06252649

• Using a radioactive drug to find cancer spread in head and neck patients

  This study is testing a new radioactive drug to see if it can help doctors find cancer spread in the lymph nodes of patients with head and neck cancer before surgery.

  Recruiting Phase 1 Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT05901545

• Using a new imaging agent to detect metastases in head and neck cancer

  This study is testing a new imaging agent to see if it can help find hidden cancer spread in people with head and neck cancer better than current methods.

  Recruiting Phase 1 Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT05747625

• Using a new imaging method to locate head and neck cancer tumors

  This study is testing a new imaging method to see if it can better find and measure head and neck cancer tumors compared to the usual imaging technique.

  Recruiting Early Phase 1 University of Alabama at Birmingham · Birmingham, Alabama · NCT05183048

• Comparing two treatments for metastatic colorectal cancer

  This study is testing which combination of treatments works better for people with metastatic colorectal cancer: one with panitumumab or the other with bevacizumab.

  Recruiting Phase 2 Charite University, Berlin, Germany · Berlin · NCT05007132

• Using panitumumab-IRDye800 to improve cancer visualization in head and neck surgery

  This study is testing a new dye called panitumumab-IRDye800 to see if it helps doctors see cancer better during surgery for head and neck cancer.

  Recruiting Phase 2 University of Alabama at Birmingham · Birmingham, Alabama · NCT04511078

• Panitumumab‑IRDye800 imaging to help surgeons find pediatric brain tumor tissue during neurosurgery

  This will test whether a fluorescent drug called panitumumab‑IRDye800 helps surgeons see tumor tissue and tiny residual disease in children and young adults having brain tumor surgery.

  Recruiting Phase 1/2 Stanford University · Stanford, California · NCT04085887

• Using a special dye to detect lung cancer during surgery

  This study is testing a special dye to see if it can help doctors find lung cancer more easily during surgery.

  Recruiting Phase 1/2 Stanford University · Palo Alto, California · NCT03582124

• Using a special dye to improve surgery for brain tumors

  This study is testing a special dye that helps doctors see brain tumors better during surgery to improve outcomes for people with malignant glioma.

  Recruiting Phase 1/2 Stanford University · Palo Alto, California · NCT03510208

• Using a special dye to improve surgery for pancreatic cancer

  This study is testing a special dye to see if it can help doctors see pancreatic cancer better during surgery and make sure they remove all of it safely.

  Recruiting Phase 1/2 Stanford University · Palo Alto, California · NCT03384238

Quick answers

How many clinical trials of Panitumumab are recruiting right now?

18, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 38 countries. The most sites are in United States (14 trials), Italy (4 trials), Australia (3 trials), France (3 trials), Greece (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1/2: 4, Phase 1: 4, Phase 3: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →